Association of group erythrocyte antigens and B-cell non-Hodgkin lymphoma

  • U. V. Tymoshenko State Institution “Institute of Haematology and Transfusiology of NAMS of Ukraine”
  • S. O. Sivkovych State Institution “Institute of Haematology and Transfusiology of NAMS of Ukraine”
  • K. G. Garkava Institute of Ecological Safety of National Aviation University
  • R. P. Pavlyuk State Institution “Institute of Haematology and Transfusiology of NAMS of Ukraine”
  • G. A. Myronenko State Institution “Institute of Haematology and Transfusiology of NAMS of Ukraine”
Keywords: antigen D, blood groups, hemoblastoses, association, risk factor


We analyzed the frequency distribution of blood groups AB0, Rhesus and Kell in patients with B-cell non-Hodgkin lymphoma. An increase of D− patients (31.0%) among ill in comparison to healthy individuals (16.5%) was found. Based on published data, we exclude weakening or alteration of the D antigen for this pathology. We found an association of B-cell non-Hodgkin lymphoma and D− phenotype. It is established that the chances of developing the disease in D− individuals is 2 times higher than for D+ individuals. However, we did not find a significant association of frequency of minor antigens Rhesus (C, c, E, e, CW), K antigen Kell system, A and B antigens AB0 system and the development of B-cell non-Hodgkin lymphoma. We have analyzed the statistics of incidence of non-Hodgkin lymphoma inWestern Europeand Asian countries. We noticed a roughly twofold increase in the incidence of non-Hodgkin lymphoma inWestern Europecompared to Asian countries, where the proportion of D− individuals is almost zero. Parallel with the results of our study, it has been found that the chances of D– persons developing B-cell non-Hodgkin lymphoma are twice as high as for D+ individuals. InUkraine,BelarusandRussiathe incidence of non-Hodgkin lymphoma is almost at the level of Asian countries even though the percentage of D– individuals corresponds to Western European countries (15–16%). This can be explained by other genetic factors, or reduction in quality of care and diagnostics in post-Soviet countries compared toWestern Europe. Thus, D antigen may have a protective role in the morbidity of non-Hodgkin lymphoma. 


Abobaker, S., Kamil, M., 2014. Incidence of breast cancer in a primary hospital in relation to AB0 blood groups system. Journal of Medical and Bioengineering 3(1), 74–77.

Akhtar, K., Mehdi, G., Sherwani, R., Sofi, L., 2010. Relationship between various cancers and AB0 blood groups – a Northern India experience. The Internet Journal of Pathology 13(1), 1–4.

Aly, R., Yousef, A., Elbably, O., 2014. Association of AB0 blood group and risk of breast cancer. Journal of Blood Disoders andTransfusion 5(9), 1–4.

Belle, G., Fisher, L.D., Heagerty, P.J., Lumley, T., 2004. Biostatistics. A methodology for the health sciences (second edition). John Wiley and Sons Inc., Hoboken, New Jersey.

Cao, X., Wen, Z-S., Sun, Y-J., Li, Y., Zhang, L., Han, Y-J., 2014. Prognostic value of AB0 blood group in patients with surgically resected colon cancer. Br. J. Cancer 111, 174–180.

Cihan, Y.B., 2014. Significance of AB0-Rh blood groups in response and prognosis in breast cancer pacients treated with radiotherapy and chemotherapy. Asian Pac. J. Cancer Prev. 15(9), 4055–4060.

Cornfield, J., 1951. A method for estimating comparative rates from clinical data. Aplications to cancer of the lung, breast and cervix. J. Natl. Cancer Inst. 11, 1269–1275.

Donskov, S.I., Morokov, V.A., 2011. Grupy krovi cheloveca. Rukovodstvo po immunoserologii [Human blood groups. Immunoserological guide]. IP Skorohodov, Moscow (in Russian).

Engel, O., Soave, A., Peine, S., Klauth, L.A., Schmid, M., Shariat, S.F., Dahlem, R., Fisch, M., Rink, M., 2015. The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radial cystectomy. World J. Urol. 33(11), 1769–1776.

Flegel, W.A., 2007. The genetics of the Rhesus blood group system. Blood Transfusion 5, 50–57.

Flegr, J., 2016. Heterozygote advantage probably maintains Rhesus factor blood group polymorphism: Ecological regression study. PLoS ONE 11(1), 1–12.

Forman, D., Bray, F., Brewster, D.H., Mbalawa, C.G., Kohler, B., Piňeros, M., Steliarova-Foucher, E., Swaminathan, R., Ferlay, J. (ed.), 2014. Cancer incidence in five continents X(164). International Agency for Research on Cancer, Lyon.

Fudenberg, H.H., Pink, J.R.L., Stites, D.P., Wang, A.C., 1972. Basic immunogenetics. Oxford University Press, New York, London, Toronto.

Gerasimova, N.D., Morokov, V.A., Donskov, S.I., 2003. Osobennosti raspredelenija antigenov sistemy Rh u onkologicheskih bol’nyh [Features Rh system antigens distribution in cancer patients]. Vestnik Sluzhby Krovi Rossii 4, 36–41 (in Russian).

Kliegman, R.M., Stanton, B.F., Geme, J.W.S., Schor, N.F., Behrman, R.E., 2011. Nelson textbook of pediatrics. Elsevier Saunders, Philadelphia.

Kumar, N., Kapoor, A., Kalwar, A., Narayan, S., Singhal, M.K., Kumar, A., Mewara, A., Bardia, M.R., 2014. Allele frequency of AB0 blood group antigen and the risk of esophageal cancer. BioMed Rsearch International 2014, 1–6.

Mansour, A.H., Mohammed, M.A., Anwar, R., Elzafrany, M.E., Omar, N.M., 2014. AB0 blood group and risk of malignancies in Egyptians. International Journal of Cancer Research 10(2), 81–95.

Myronenko, G.A., 2011. Asociatyvnyj zvyazok erytrocytarnogo antygenu CW systemy Rhesus z avtoimunnoyu gemolitychnoyu anemiyeyu [Associative connection of the erythrocyte antigene CW of the Rhesus system with the autoimmune haemolytic anemia]. Ukrainian Journal of Hematology and Transfusiology 4(11), 26–29 (in Ukrainian).

Myronenko, G.A., Tymoshenko, U.V., 2012. Asociatyvnyj zvyazok ekspresiyi erytrocytarnyx antygeniv systemy AB0, Rezus ta Kell z avtoimunnoyu gemolitychnoyu anemiyeyu [Associacion of erythrocyne antigens AB0, Rh and Kell with autoimmune hemolytic anemia]. Hematolohiya i Perelyvannya Krovi 36, 163–169 (in Ukrainian).

Nakashidze, I., Diasamidze, A., Baratashvili, D., Nagervadze, M., Alibegashvili, M., Ramishvili, L., Gordeziani, M., Khazaradze, A., Kotrikadze, N., 2014. Alteration of sex and non-sex hormones and distribution features of blood AB0 system groups among the women with uterine body tumors. Journal of Cancer Therapy 5, 411–419.

Nayak, V., 2016. Frequency of AB0-Rh blood group in leukemia. Indian Journal of Applied Research 6(2), 419–420.

Newton, R.M., Buehler, S.K., Crumley, J., Marshall, W.H., 1979. Rhesus haplotypes in familial Hodgkin’s disease. Vox Sanguinis 37(3), 158–165.

Novaretti, M.C.Z., Domingues, A.E., Manhani, R., Pinto, E.M., Dorlhiak-Llacer, P.E., Camone, D.A.F., 2008. AB0 genotyping in leukemia patients reveals new AB0 variant alleles. Genetics and Molecular Research 7(1), 87–94.

Pelzer, U., Klein, F., Bahra, M., Sinn, M., Dörken, B., Neuhaus, P., Meyer, O., Riess, H., 2013. Blood group determinates incidence for pancreatic cancer in Germany. Frontiers in Physiology 4, Article 118.

Ragnarsson, G., Eiriksdottir, G., Johannsdottir, J.T., Jonasson, J.G., Egilsson, V., Ingvarsson, S., 1999. Loss of geterozygosity at chromosome 1p in different solid human tumors: Association with survival. Br. J. Cancer 79, 1468–1474.

Shérif-Zahar, B., Bony, V., Steffennsen, R., Gane, P., Raynal, V., Goosens, D., Laursen, J.S., Varming, K., Jersild, C., Cartron, J-P., 1998. Shift from Rh-positive to Rh-negative phenotype caused by somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia. Br. J. Haematol. 102, 1263–1270.

Smith, D.R., Beh, E.J., 2012. Measuring ‘Risk’ in occupational health studies: Standard methods and some alternatives for epidemiological research. Industrial Health 50, 463–465.

Upma Fotra, R., 2016. Ovarian malignancies in relation to AB0 blood groups and Rh factor. International Journal of Advanced Research 4(5), 1115–1118.

Urun, Y., Utkan, G., Cangir, A.K., Oksuzoglu, O.B., Ozdemir, N., Oztuna, D.G., Kocaman, G., Coşkun, H.Ş., Kaplan, M.A., Yuksel, C., Demirkazik, A., Icli, F., 2013. Associacion of AB0 blood group and risk of lung cancer in a multicenter study in Turkey. Asian Pac. J. Cancer Prev. 14(5), 2801–2803.

Westhoff, C.M., 2007. The structure and function of the Rh antigen complex. Seminars in Hematology 44(1), 42–50.

Winters, J.L., Howard, D.S., 2001. Red blood cell antigen changes in malignancy: Case report and review. Immunohematology 17(1), 1–9.

Yuzhalin, A.E., Kutikhin, A.G., 2012. AB0 and RH blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia. Asian Pac. J. Cancer Prev. 13(10), 5091–5096.

Zand, A.M., Imani, S., Saadati, M., Borna, H., Ziaei, R., Hossein, H., 2010. Effect of age, gender and blood group on blood cancer types. Kowsar Medical Journal 15(2), 111–114.

Zand, A.M., Imani, S., Saadati, M., Ziaei, R., Borna, H., Zaefizadeh, M., Shazad, B., 2012. Statistical approach to discovery of factors impacting on emergence of blood cancers in Iran. Asian Pac. J. Cancer Prev. 13(12), 5965–5967.

Zareckaja, J.M., 1983. Klinicheskaja immunogenetika [Clinical immunogenetics]. Medicina, Moscow (in Russian).

Zhang, B.L., He, N., Huang, Y.B., Song, F.G., Chen, K.X., 2014. AB0 blood groups and risk of cancer: A systematic review and meta-analysis. Asian Pac. J. Cancer Prev. 15(11), 4643–4650.

How to Cite
Tymoshenko, U. V., Sivkovych, S. O., Garkava, K. G., Pavlyuk, R. P., & Myronenko, G. A. (2016). Association of group erythrocyte antigens and B-cell non-Hodgkin lymphoma. Regulatory Mechanisms in Biosystems, 7(2), 112–117.